Drug
Humira IN
Humira IN: highest development phase Phase 3, developed by Biocon. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Biocon
Trials
| Drug | Phase | Indication |
|---|---|---|
| Humira 40 MG in Prefilled Syringe NCT05637515 | Phase 3 | Moderate Chronic Plaque Psoriasis |
Latest
No recent events.
Follow Humira IN on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.